CH 5450

CAS No. 252557-97-4

CH 5450 ( Z-Ile-Glu-Pro-Phe-Ome )

Catalog No. M22282 CAS No. 252557-97-4

CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a short peptide inhibitor of chymase in the human heart.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 177 In Stock
5MG 312 In Stock
10MG 447 In Stock
25MG 714 In Stock
50MG 1017 In Stock
100MG 1368 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CH 5450
  • Note
    Research use only, not for human use.
  • Brief Description
    CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a short peptide inhibitor of chymase in the human heart.
  • Description
    CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a short peptide inhibitor of chymase in the human heart.
  • Synonyms
    Z-Ile-Glu-Pro-Phe-Ome
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Chymase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    252557-97-4
  • Formula Weight
    652.73
  • Molecular Formula
    C34H44N4O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:43 mg/mL (65.88 mM)
  • SMILES
    O=C(OC)[C@@H](NC([C@H]1N(C([C@@H](NC([C@@H](NC(OCC2=CC=CC=C2)=O)[C@@H](C)CC)=O)CCC(O)=O)=O)CCC1)=O)CC3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bastos M, et al. Inhibitors of human heart chymase based on a peptide library. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6738-42.
molnova catalog
related products
  • Levobunolol hydrochl...

    Levobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.

  • Ganoderal A

    The oxygenated sterols( 26-oxygenosterols ganoderol A, ganoderol B, ganoderal A, and ganoderic acid Y) from G. lucidum can inhibit cholesterol biosynthesis via conversion of acetate or mevalonate as a precursor of cholesterol.

  • Laurocapram

    Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.